{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:06:30Z","timestamp":1793387190518,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T00:00:00Z","timestamp":1678492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence, management, and clinical outcomes of cholangiocarcinoma in Africa are unknown. The aim is to conduct a comprehensive systematic review on the epidemiology, management, and outcomes of cholangiocarcinoma in Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We searched PubMed, EMBASE, Web of Science and CINHAL from inception up to November 2019 for studies on cholangiocarcinoma in Africa. The results reported follow PRISMA guidelines. Quality of studies and risk of bias were adapted from a standard quality assessment tool. Descriptive data were expressed as numbers with proportions and Chi-squared test was used to compare proportions.\n                      <jats:italic>P<\/jats:italic>\n                      values\u2009&lt;\u20090.05 were considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 201 citations were identified from the four databases. After excluding duplicates, 133 full texts were reviewed for eligibility, and 11 studies were included. The 11 studies are reported from 4 countries only: 8 are from North Africa (Egypt 6 and Tunisia 2), and 3 in Sub-Saharan Africa (2 in South Africa, 1 in Nigeria). Ten studies reported management and outcomes, while one study reported epidemiology and risk factors. Median age for\u00a0cholangiocarcinoma\u00a0ranged between 52 and 61\u00a0years. Despite the\u00a0proportion with\u00a0cholangiocarcinoma\u00a0being higher among males than females in Egypt, this gender disparity could not be demonstrated in other African\u00a0countries. Chemotherapy is mainly used for palliative care. Surgical interventions are curative and prevent cancer progression. Statistical analyses were performed with Stata 15.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      The known global major risk factors such as primary sclerosing cholangitis,\n                      <jats:italic>Clonorchis sinensis<\/jats:italic>\n                      and\n                      <jats:italic>Opisthorchis viverrini<\/jats:italic>\n                      infestation are rare. Chemotherapy treatment was mainly used for palliative treatment and was reported in three studies. Surgical intervention was described in at least 6 studies as a curative modality of treatment. Diagnostic capabilities such as radiographic imaging and endoscopic are lacking across the continent which most likely plays a role in accurate diagnosis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-023-02687-6","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:24:11Z","timestamp":1679847851000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Systematic review of cholangiocarcinoma in Africa: epidemiology, management, and clinical outcomes"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-6772","authenticated-orcid":false,"given":"Akwi W.","family":"Asombang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel","family":"Chishinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhand F.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alick","family":"Nkhoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Chipaila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright","family":"Nsokolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Manda-Mapalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Filipe G.","family":"Montiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Banda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulwinder S.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,11]]},"reference":[{"key":"2687_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S1084952102001258","volume":"13","author":"L Libbrecht","year":"2002","unstructured":"Libbrecht L, Roskams T. Hepatic progenitor cells in human liver diseases. Semin Cell Dev Biol. 2002;13:389\u201396.","journal-title":"Semin Cell Dev Biol"},{"key":"2687_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39:19\u201331. https:\/\/doi.org\/10.1111\/liv.14095.","journal-title":"Liver Int"},{"key":"2687_CR3","doi-asserted-by":"crossref","unstructured":"Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002;2 [cited 2022 Mar 16] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11991810\/","DOI":"10.1186\/1471-2407-2-10"},{"key":"2687_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11894-011-0178-8","volume":"13","author":"H Charbel","year":"2011","unstructured":"Charbel H, Al-Kawas FH. Cholangiocarcinoma: epidemiology, risk factors, pathogenesis, and diagnosis. Curr Gastroenterol Rep. 2011;13:182\u20137.","journal-title":"Curr Gastroenterol Rep"},{"key":"2687_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cld.567","volume":"8","author":"N Razumilava","year":"2016","unstructured":"Razumilava N, Gores GJ. Surveillance for cholangiocarcinoma in patients with primary Sclerosing cholangitis: effective and justified? Clin liver Dis. 2016;8:43\u20137.","journal-title":"Clin liver Dis"},{"issue":"Suppl 1","key":"2687_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, et al. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98\u2013107.","journal-title":"Liver Int"},{"key":"2687_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz B, Komuta M, Roskams T, et al. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;8:512\u201322.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2687_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","volume":"248","author":"I Endo","year":"2008","unstructured":"Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248:84\u201396.","journal-title":"Ann Surg"},{"key":"2687_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755\u201362.","journal-title":"Ann Surg"},{"key":"2687_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/lt.24955","volume":"24","author":"N Goldaracena","year":"2018","unstructured":"Goldaracena N, Gorgen A, Sapisochin G. Current status of liver transplantation for cholangiocarcinoma. Liver Transpl. 2018;24:294\u2013303.","journal-title":"Liver Transpl"},{"key":"2687_CR11","first-page":"567","volume":"181","author":"AN Kimmings","year":"1995","unstructured":"Kimmings AN, Van Deventer SJH, Obertop H, et al. Inflammatory and immunologic effects of obstructive jaundice: pathogenesis and treatment. J Am Coll Surg. 1995;181:567\u201381.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"2687_CR12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.4251\/wjgo.v13.i12.2050.PMID:35070041;PMCID:PMC8713328","volume":"13","author":"T Mocan","year":"2021","unstructured":"Mocan T, Horhat A, Mois E, Graur F, Tefas C, Craciun R, Nenu I, Sp\u00e2rchez M, Sparchez Z. Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: when and how? World J Gastrointest Oncol. 2021;13(12):2050\u201363. https:\/\/doi.org\/10.4251\/wjgo.v13.i12.2050.PMID:35070041;PMCID:PMC8713328.","journal-title":"World J Gastrointest Oncol"},{"key":"2687_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.suronc.2007.08.010","volume":"16","author":"SC Cunningham","year":"2007","unstructured":"Cunningham SC, Choti MA, Bellavance EC, et al. Palliation of hepatic tumors. Surg Oncol. 2007;16:277\u201391.","journal-title":"Surg Oncol"},{"key":"2687_CR14","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1093\/carcin\/bgw066","volume":"37","author":"S Mimaki","year":"2016","unstructured":"Mimaki S, Totsuka Y, Suzuki Y, et al. Hypermutation and unique mutational signatures of occupational cholangiocarcinoma in printing workers exposed to haloalkanes. Carcinogenesis. 2016;37:817.","journal-title":"Carcinogenesis"},{"issue":"6","key":"2687_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1667\/rr3095","volume":"160","author":"LB Travis","year":"2003","unstructured":"Travis LB, Hauptmann M, Gaul LK, et al. Site-specific cancer incidence and mortality after cerebral angiography with radioactive thorotrast. Radiat Res. 2003;160(6):691\u2013706. https:\/\/doi.org\/10.1667\/rr3095.","journal-title":"Radiat Res"},{"key":"2687_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ijc.31835","volume":"144","author":"EE McGee","year":"2019","unstructured":"McGee EE, Castro FA, Engels EA, et al. Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults. Int J Cancer. 2019;144:707\u201317.","journal-title":"Int J Cancer"},{"key":"2687_CR17","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5483\/BMBRep.2016.49.11.109","volume":"49","author":"TS Kim","year":"2016","unstructured":"Kim TS, Pak JH, Kim JB, et al. Clonorchis sinensis, an oriental liver fluke, as a human biological agent of cholangiocarcinoma: a brief review. BMB Rep. 2016;49:590\u20137.","journal-title":"BMB Rep"},{"key":"2687_CR18","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.ijpara.2005.07.010","volume":"35","author":"S Mas-Coma","year":"2005","unstructured":"Mas-Coma S, Bargues MD, Valero MA. Fascioliasis and other plant-borne trematode zoonoses. Int J Parasitol. 2005;35:1255\u201378.","journal-title":"Int J Parasitol"},{"key":"2687_CR19","doi-asserted-by":"publisher","first-page":"13418","DOI":"10.3748\/wjg.v21.i48.13418","volume":"21","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Kim JS, Joo MK, et al. Hepatolithiasis and intrahepatic cholangiocarcinoma: a review. World J Gastroenterol. 2015;21:13418.","journal-title":"World J Gastroenterol"},{"key":"2687_CR20","doi-asserted-by":"crossref","unstructured":"Thun MJ, Linet MS, Cerhan JR, et al. Schottenfeld and fraumeni Cancer epidemiology and prevention, fourth edition. Schottenfeld Fraumeni Cancer Epidemiol. Prev. Fourth Ed. 2017;1\u20131308.","DOI":"10.1093\/oso\/9780190238667.001.0001"},{"key":"2687_CR21","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1007\/s13277-014-1939-4","volume":"35","author":"JS Li","year":"2014","unstructured":"Li JS, Han TJ, Jing N, et al. Obesity and the risk of cholangiocarcinoma: a meta-analysis. Tumour Biol. 2014;35:6831\u20138.","journal-title":"Tumour Biol"},{"key":"2687_CR22","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamainternmed.2016.1531","volume":"176","author":"JL Faillie","year":"2016","unstructured":"Faillie JL, Yu OH, Yin H, et al. Association of bile duct and gallbladder diseases with the use of incretin-based drugs in patients with Type 2 diabetes mellitus. JAMA Intern Med. 2016;176:1474\u201381.","journal-title":"JAMA Intern Med"},{"key":"2687_CR23","doi-asserted-by":"crossref","unstructured":"Wong WCW, Cheung CSK, Hart GJ. Development of a quality assessment tool for systematic reviews of observational studies (QATSO) of HIV prevalence in men having sex with men and associated risk behaviours. Emerg. Themes Epidemiol 2008;5[cited 2022 Mar 16] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19014686\/","DOI":"10.1186\/1742-7622-5-23"},{"key":"2687_CR24","unstructured":"Pattern of biliary tract carcinoma at the University College Hospital, Ibadan. | Semantic Scholar. [cited 2022 Mar 16] Available from: https:\/\/www.semanticscholar.org\/paper\/Pattern-of-biliary-tract-carcinoma-at-the-College-To-Jo\/70269d41cbc5b12b706c2f6598f8d5478eced64f"},{"key":"2687_CR25","doi-asserted-by":"publisher","first-page":"iv39","DOI":"10.1093\/annonc\/mdv233.138","volume":"26","author":"RY Ben","year":"2015","unstructured":"Ben RY, Labidi S, Meganem H, et al. P-138 Biliary tract cancers: epidemiology and prognosis. Ann Oncol. 2015;26:iv39.","journal-title":"Ann Oncol"},{"key":"2687_CR26","doi-asserted-by":"publisher","first-page":"ix82","DOI":"10.1016\/S0923-7534(21)00422-1","volume":"27","author":"S Labid","year":"2016","unstructured":"Labid S, Nasri M, El Benna H, et al. 265P Epidemiology, outcome and prognostic factors of biliary tract cancer in the Tunisian population. Ann Oncol. 2016;27:ix82\u20133.","journal-title":"Ann Oncol"},{"key":"2687_CR27","first-page":"12","volume":"45","author":"D Clarke","year":"2007","unstructured":"Clarke D, Thomson S, Anderson F, et al. Palliation of malignant hilar obstruction at a single centre\u2013review of operative and non-operative techniques - PubMed. S Afr J Surg. 2007;45:12\u20136.","journal-title":"S Afr J Surg"},{"key":"2687_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7196\/sajs.1302","volume":"50","author":"AJ Lawson","year":"2012","unstructured":"Lawson AJ, Beningfield SJ, Krige JEJ, et al. Percutaneous transhepatic self-expanding metal stents for palliation of malignant biliary obstruction. S Afr J Surg. 2012;50:54\u201360.","journal-title":"S Afr J Surg"},{"key":"2687_CR29","first-page":"414","volume":"57","author":"E El-Hanafy","year":"2010","unstructured":"El-Hanafy E. Pre-operative biliary drainage in hilar cholangiocarcinoma, benefits and risks, single center experience. Hepatogastroenterology. 2010;57:414\u20139.","journal-title":"Hepatogastroenterology"},{"key":"2687_CR30","doi-asserted-by":"publisher","first-page":"436","DOI":"10.4240\/wjgs.v8.i6.436","volume":"8","author":"MA ElWahab","year":"2016","unstructured":"ElWahab MA, El Nakeeb A, El Hanafy E, et al. Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors. World J Gastrointest Surg. 2016;8:436.","journal-title":"World J Gastrointest Surg"},{"key":"2687_CR31","first-page":"5","volume":"53","author":"M Abdel Wahab","year":"2006","unstructured":"Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma - PubMed. Hepatogastroenterology. 2006;53:5\u201310.","journal-title":"Hepatogastroenterology"},{"key":"2687_CR32","first-page":"337","volume":"50","author":"MA Wahab","year":"2003","unstructured":"Wahab MA, Sultan A, Elgwalby N, et al. Outcome after resection of central cholangiocarcinoma: preliminary experience with 46 patients in a single center. Hepatogastroenterology. 2003;50:337\u201341.","journal-title":"Hepatogastroenterology"},{"key":"2687_CR33","first-page":"321","volume":"59","author":"M Abdel-Wahab","year":"2012","unstructured":"Abdel-Wahab M, Sultan AM, Salah T, et al. Caudate lobe resection with major hepatectomy for central cholangiocarcinoma: is it of value? Hepatogastroenterology. 2012;59:321\u20134.","journal-title":"Hepatogastroenterology."},{"key":"2687_CR34","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ijsu.2014.05.058","volume":"12","author":"M Abdelwahab","year":"2014","unstructured":"Abdelwahab M, El Nakeeb A, Salah T, et al. Hilar cholangiocarcinoma in cirrhotic liver: a case-control study. Int J Surg. 2014;12:762\u20137.","journal-title":"Int J Surg"},{"key":"2687_CR35","first-page":"1626","volume":"54","author":"M Abdel Wahab","year":"2007","unstructured":"Abdel Wahab M, Mostafa M, Salah T, et al. Epidemiology of hilar cholangiocarcinoma in Egypt: single center study. Hepatogastroenterology. 2007;54:1626\u201331.","journal-title":"Hepatogastroenterology"},{"key":"2687_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0168-8278(02)80753-X","volume":"36","author":"A Mall","year":"2002","unstructured":"Mall A, Hall P, Barnard R, et al. The expression of mucin in cholangiocarcinoma. An Immunohistochemical study. J Hepatol. 2002;36:211.","journal-title":"J Hepatol"},{"key":"2687_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ijc.2910490206","volume":"49","author":"JG Mati","year":"1991","unstructured":"Mati JG, Kenya P, Kungu A, et al. Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. Int J Cancer. 1991;49:182\u20135.","journal-title":"Int J Cancer"},{"key":"2687_CR38","doi-asserted-by":"publisher","unstructured":"Primary Sclerosing Cholangitis in a cohort of South African patients with Inflammatory Bowel Disease at Charlotte Maxeke Johannesburg Academic Hospital | South African Gastroenterology Review. [cited 2022 Mar 17] Available from: https:\/\/journals.co.za\/doi\/https:\/\/doi.org\/10.10520\/EJC-12926aa0ff","DOI":"10.10520\/EJC-12926aa0ff"},{"key":"2687_CR39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/gut.41.5.688","volume":"41","author":"P Kelly","year":"1997","unstructured":"Kelly P, Patchett S, McCloskey D, et al. Sclerosing cholangitis, race and sex. Gut. 1997;41:688\u20139.","journal-title":"Gut"},{"key":"2687_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/BF01660719","volume":"3","author":"I Segal","year":"1988","unstructured":"Segal I. Ulcerative colitis in a developing country of Africa: the Baragwanath experience of the first 46 patients. Int J Colorectal Dis. 1988;3:222\u20135.","journal-title":"Int J Colorectal Dis"},{"key":"2687_CR41","first-page":"221","volume":"41","author":"ATA Morsy","year":"2011","unstructured":"Morsy ATA, Al-Mathal EM. Clonorchis sinensis a new report in Egyptian employees returning back from Saudi Arabia. J Egypt Soc Parasitol. 2011;41:221\u20135.","journal-title":"J Egypt Soc Parasitol"},{"key":"2687_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1349-7006.2009.01458.x","volume":"101","author":"HR Shin","year":"2010","unstructured":"Shin HR, Oh JK, Masuyer E, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci. 2010;101:579\u201385.","journal-title":"Cancer Sci"},{"key":"2687_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1439-0450.2005.00872.x","volume":"52","author":"AM Phiri","year":"2005","unstructured":"Phiri AM, Phiri IK, Sikasunge CS, et al. Prevalence of fasciolosis in Zambian cattle observed at selected abattoirs with emphasis on age, sex and origin. J Vet Med B Infect Dis Vet Public Health. 2005;52:414\u20136.","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"2687_CR44","first-page":"5","volume":"53","author":"M Abdel Wahab","year":"2006","unstructured":"Abdel Wahab M, Fathy O, Elghwalby N, et al. Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepatogastroenterology. 2006;53:5\u201310.","journal-title":"Hepatogastroenterology"},{"issue":"1","key":"2687_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/hep.31653","volume":"74","author":"K Sato","year":"2021","unstructured":"Sato K, Zhang W, Safarikia S, Isidan A, Chen AM, Li P, Francis H, Kennedy L, Baiocchi L, Alvaro D, Glaser S, Ekser B, Alpini G. Organoids and spheroids as models for studying cholestatic liver injury and cholangiocarcinoma. Hepatology. 2021;74(1):491\u2013502.","journal-title":"Hepatology"},{"issue":"5","key":"2687_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41419-020-2509-x","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang G, Wang Q, Liang N, Xue H, Yang T, Chen X, Qiu Z, Zeng C, Sun T, Yuan W, Liu C, Chen Z, He X. Oncogenic driver genes and tumor microenvironment determine the type of liver cancer. Cell Death Dis. 2020;11(5):313.","journal-title":"Cell Death Dis"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-02687-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-02687-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:25:01Z","timestamp":1679847901000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-02687-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2687"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-02687-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1972481\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,11]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authours declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"66"}}